ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 01/23/2025 at 22:05, 1 year 4 months ago

Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn’s and Colitis Organization 20th Annual Congress
Abivax announces presentation of seven abstracts for Obefazimod in ulcerative colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress

Abivax Obefazimod Ulcerative Colitis Clinical Trials ECCO
PRESS RELEASE

published on 01/09/2025 at 17:44, 1 year 5 months ago

Abivax franchit une étape clé dans le recrutement de l’essai de phase 3 ABTECT
Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT pour le traitement de la RCH. Objectif de recrutement proche de 82%. Premiers résultats attendus en 2025

Abivax Recrutement Phase 3 ABTECT RCH
BRIEF

published on 01/09/2025 at 17:40, 1 year 5 months ago

Abivax Reaches Key Enrollment Milestone in Phase 3 ABTECT Trial

Abivax Obefazimod Ulcerative Colitis Phase 3 Trial Clinical Results
BRIEF

published on 01/09/2025 at 17:40, 1 year 5 months ago

Abivax franchit une étape clé dans le recrutement de l'essai de phase 3 ABTECT

Abivax Obefazimod Rectocolite Hémorragique Essai De Phase 3 Résultats Cliniques
PRESS RELEASE

published on 01/09/2025 at 17:35, 1 year 5 months ago

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
Abivax achieves key milestone in Phase 3 ABTECT trial enrollment with 82% of target participants enrolled for evaluating obefazimod in ulcerative colitis, aiming for NDA submission by H2 2026

Abivax Obefazimod Ulcerative Colitis Phase 3 ABTECT Trial
BRIEF

published on 12/23/2024 at 22:10, 1 year 5 months ago

Abivax Announces Board Resignation

Abivax Obefazimod Board Resignation Truffle Capital Philippe Pouletty
BRIEF

published on 12/23/2024 at 22:10, 1 year 5 months ago

Abivax annonce la démission de son conseil d'administration

Abivax Obefazimod Démission Du Conseil D'administration La Capitale De La Truffe Philippe Pouletty
PRESS RELEASE

published on 12/23/2024 at 22:05, 1 year 5 months ago

Abivax annonce une modification de la composition de son Conseil d'administration
Abivax annonce la démission du Dr Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration. Plus d'informations sur www.abivax.com

Abivax Conseil D'administration Rectocolite Hémorragique Démission Maladies Inflammatoires
PRESS RELEASE

published on 12/23/2024 at 22:05, 1 year 5 months ago

Abivax annonce une modification de la composition de son Conseil d'administration
Abivax annonce la démission du Dr. Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration pour soutenir le développement de thérapies. Détails sur www.abivax.com

Innovation Abivax Conseil D'administration Démission Thérapies
PRESS RELEASE

published on 12/23/2024 at 22:05, 1 year 5 months ago

Abivax Announces a Change to the Composition of its Board of Directors
Abivax announces a change in its Board of Directors composition as Dr. Philippe Pouletty resigns due to new appointment. The company expresses gratitude for his contributions

Board Of Directors Resignation Abivax Therapeutics Dr. Philippe Pouletty

Published on 06/22/2026 at 23:25, 2 hours 20 minutes ago

Infield Minerals Announces Intention to Issue Shares for Kings Canyon Gold Property Option Payment
Published on 06/22/2026 at 23:05, 2 hours 40 minutes ago

Gamma Resources Settles Remaining Balance of Outstanding Debt
Published on 06/22/2026 at 21:05, 4 hours 40 minutes ago

RUM Announces Voting Results From Annual General Meeting of Shareholders
Published on 06/22/2026 at 19:45, 6 hours ago

Trans Canada Gold Appoints Paradigm Drilling Ltd. for Drilling at the Harrison Lake District Scale Gold Project, Drilling to Commence Shortly
Published on 06/22/2026 at 15:58, 9 hours 47 minutes ago

Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement

View all ACCESSWIRE

Published on 06/23/2026 at 01:35, 9 minutes ago

DoH and Sanofi Partner to Advance Vaccine Innovation
Published on 06/22/2026 at 21:07, 4 hours 37 minutes ago

EQS-Adhoc: RWE Aktiengesellschaft: RWE sets placement price for shares from capital measure and raises gross proceeds of 4 billion EUR
Published on 06/22/2026 at 20:50, 4 hours 54 minutes ago

Ethlabs, Founded by Former Ethereum Foundation Contributors and Funded by Bitmine, Sharplink and Joe Lubin, Launches to Accelerate Ethereum's Institutional Supercycle
Published on 06/22/2026 at 20:32, 5 hours 12 minutes ago

EQS-Adhoc: Deutsche Konsum Real Estate AG: Daniel Löhken appointed Chief Executive Officer of the Company and Dr Kai Gregor Klinger appointed new Chairman of the Supervisory Board
Published on 06/22/2026 at 19:27, 6 hours 18 minutes ago

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings

View all EQS

Published on 06/22/2026 at 18:45, 7 hours ago

Governance evolution
Published on 06/22/2026 at 18:45, 7 hours ago

ÉVOLUTION DE LA GOUVERNANCE
Published on 06/22/2026 at 18:16, 7 hours 28 minutes ago

ANTOINE FREY INCREASES HIS STAKE IN FREY
Published on 06/22/2026 at 18:16, 7 hours 28 minutes ago

ANTOINE FREY SE RENFORCE AU CAPITAL DE FREY
Published on 06/22/2026 at 18:00, 7 hours 45 minutes ago

GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION

View all LES ECHOS COMFI WIRE

News